# Immunocore (IMCR) — Overview

IMCR · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/imcr

## Price

Last close $29.48 on Oct 15, 2026. 52-week range $27.79 – $40.22.

## Company profile

Immunocore Holdings PLC is a commercial-stage biotechnology company. Using its ImmTAX platform, the company is developing a deep pipeline in multiple therapeutic areas, including clinical stage programs in oncology and infectious disease, pre-clinical programs in autoimmune disease, and earlier pre-clinical programs across three therapeutic areas. The company's main product, KIMMTRAK, is used for the treatment of unresectable or metastatic uveal melanoma (mUM). The other drug candidates in its pipeline include Brenetafusp, IMC-P115C, IMC-T119C, IMC-R117C, IMC-S118AI, IMC-U120AI, and others, being developed as a potential treatment for various oncology, infectious, and autoimmune diseases.

## Financials

| Metric | Value |
| --- | --- |
| Revenue (trailing twelve months) | $430.8M |
| Revenue (quarter) | $115.9M |
| Revenue growth (year over year) | 18.34% |
| Gross profit (trailing twelve months) | $426.0M |
| Gross margin | 98.90% |
| Net income (trailing twelve months) | −$18.1M |
| Net income (quarter) | −$808,000.00 |
| Net income growth (year over year) | 92.16% |
| Net margin | -4.20% |
| Return on equity | -4.47% |
| EPS (trailing twelve months) | −$0.36 |
| Book value per share | $8.15 |
| P/E (trailing twelve months) | — |
| Price to book | 3.6 |
| Debt to assets | 62.50% |
| Payout ratio | 0.00% |
| Dividend yield | 0.00% |

## Frequently Asked Questions

### Is Immunocore (IMCR) profitable?

No. Immunocore reported a net loss of $18.1M over the trailing twelve months.

### How much revenue does Immunocore (IMCR) make?

Immunocore generated $430.8M in revenue over the trailing twelve months, up 18.34% year over year.

### How do I buy stock in Immunocore (IMCR)?

IMCR trades commission-free with a Light Horse Securities brokerage account — from the mobile app, the web at [Light Horse Dashboard](https://portal.lighthorse.io), the trading API, or an [AI agent connected over MCP](/instructions/ai/claude). The trade panel on this page places the order once you are signed in.

---

Quotes and charts are not real-time and must not be relied on for trade decisions or valuation.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).